- Headquarters
- Shanghai
- Employees
- 51–200
- Business Model
- B2B
- Website
- asieris.com
- Total Funding
- $14.0M
- Last Round
- $14.0M Series D
- Type
- Public
About
Clinical-stage biopharmaceutical company focused on developing novel therapies for oncology and urology indications in China and globally.
Summary
Asieris Pharmaceuticals is a Biotech company based in Shanghai, China. It has raised $14.0M in total.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform